Picture of Aptose Biosciences logo

APS Aptose Biosciences Balance Sheet

0.000.00%
ca flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual balance sheet for Aptose Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments15.797.612279.147
Prepaid Expenses
Total Other Current Assets
Total Current Assets16.598.812581.749.5
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.3841.711.190.7881.51
Total Assets16.910012682.551
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities2.795.546.818.1712.3
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities2.796.557.358.2913.3
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity14.193.911974.237.7
Total Liabilities & Shareholders' Equity16.910012682.551
Total Common Shares Outstanding